Product Details
Product Name:
Nexopamil racemate |
CAS No.:
116759-35-4 |
Purity:
98.61% |
Supply Ability:
10g |
Release date:
2024/11/20 |
Product Introduction
Bioactivity
Name | Nexopamil racemate |
Description | Nexopamil racemate((Rac)-Nexopamil) is a racemate of Nexopamil. The Nexopamil racemate has potential anti-asthmatic and anti-ulcer activity. |
In vitro | In vitro, Nexopamil most potently inhibits serotonin-induced platelet aggregation in dog platelet-rich plasma (PRP) with an IC50 of 81 nM [1]. |
In vivo | Within the first 30 minutes after application, Nexopamil (0.05 mg/kg) completely abolishes cyclic flow reductions (CFRs) without significantly altering hemodynamics [1]. |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | Nexopamil racemate |
Inhibitors Related | Nisoldipine | Alverine citrate | Dapoxetine hydrochloride | CLOZAPINE N-OXIDE | L-Ascorbic acid | Lanthanum(III) chloride heptahydrate | Ethyl cinnamate | 1-Octanol | Trazodone hydrochloride | Mianserin hydrochloride |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:755013-59-3
$2580.00 / 50mg
-
CAS:851599-82-1
$165.00 / 1mg
-
CAS:145743-63-1
$117.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$120.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |